U.S. flag

An official website of the United States government

NM_000384.3(APOB):c.5560G>A (p.Asp1854Asn) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 19, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002343407.4

Allele description [Variation Report for NM_000384.3(APOB):c.5560G>A (p.Asp1854Asn)]

NM_000384.3(APOB):c.5560G>A (p.Asp1854Asn)

Gene:
APOB:apolipoprotein B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p24.1
Genomic location:
Preferred name:
NM_000384.3(APOB):c.5560G>A (p.Asp1854Asn)
HGVS:
  • NC_000002.12:g.21011308C>T
  • NG_011793.1:g.37766G>A
  • NM_000384.3:c.5560G>AMANE SELECT
  • NP_000375.3:p.Asp1854Asn
  • NC_000002.11:g.21234180C>T
  • NM_000384.2:c.5560G>A
Protein change:
D1854N
Links:
dbSNP: rs138005301
NCBI 1000 Genomes Browser:
rs138005301
Molecular consequence:
  • NM_000384.3:c.5560G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002649996Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Aug 19, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Diamonds in the rough: rare variants scratch the surface.

Podolak E.

Biotechniques. 2010 Oct;49(4):697, 699, 701. No abstract available.

PubMed [citation]
PMID:
21033204

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Pelusi S, Baselli G, Pietrelli A, Dongiovanni P, Donati B, McCain MV, Meroni M, Fracanzani AL, Romagnoli R, Petta S, Grieco A, Miele L, Soardo G, Bugianesi E, Fargion S, Aghemo A, D'Ambrosio R, Xing C, Romeo S, De Francesco R, Reeves HL, Valenti LVC.

Sci Rep. 2019 Mar 6;9(1):3682. doi: 10.1038/s41598-019-39998-2.

PubMed [citation]
PMID:
30842500
PMCID:
PMC6403344
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV002649996.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.D1854N variant (also known as c.5560G>A), located in coding exon 26 of the APOB gene, results from a G to A substitution at nucleotide position 5560. The aspartic acid at codon 1854 is replaced by asparagine, an amino acid with highly similar properties. This variant has been detected in a hypercholesterolemia cohort (Gill PK et al. J Clin Lipidol Nov;15:79-87). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024